Camp4 Therapeutics Corporation · NASDAQ:CAMP
Amir Nashat reported a 6.30% stake in Camp4 Therapeutics Corporation (Schedule 13D/A)
Event Aug 13, 2026 · Filed Aug 19, 2026
Amir Nashat reported a 6.30% stake in Camp4 Therapeutics Corporation, 3,932,251 shares, with active intent on Aug 13, 2026. Filed Aug 19, 2026 (Schedule 13D/A).
- Stake
- 6.30%
- Shares
- 3,932,251
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Polaris Management Co. VII, L.L.C. | 4.80% | 3,023,161 |
| Polaris Partners VII, L.P. | 4.50% | 2,825,500 |
| Polaris Entrepreneurs' Fund VII, L.P. | 0.30% | 197,661 |
| Polaris Partners GP X, L.L.C. | 1.40% | 909,090 |
| Polaris Partners X, L.P. | 1.40% | 909,090 |
| Amir Nashat | 6.30% | 3,932,251 |
| Brian Chee | 1.40% | 909,090 |
| Amy Schulman | 1.40% | 909,090 |
Source
Related
- Camp4 Therapeutics Corporation
- Amir Nashat
- Camp4 Therapeutics Corporation shareholders
- Schedule 13D/A · Amir Nashat · Sep 11, 2025
- Form 4 · Gold Kelly · Sep 2, 2026
- Form 4 · Schwab Andrew J. · Aug 31, 2026
- Schedule 13D/A · Schwab Andrew J. · Aug 31, 2026
- Form 4 · Schwab Andrew J. · Aug 26, 2026
- Form 4 · Schwab Andrew J. · Aug 21, 2026